Spontaneous recovery of chemotherapy-induced primary ovarian failure: Implications for management

Clinical Endocrinology

Volumn 46, Issue 2, 1997, Pages 217-219

  Nasir, Joohi ^a,b   Walton, Christopher ^a   Lindow, Stephen W ^a   Masson, Ewan A ^a  

^a Hull Royal Informary   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; NORGESTREL; VINCRISTINE;

ADOLESCENT; AMENORRHEA; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; FEMALE; HORMONE SUBSTITUTION; HUMAN; OVARY FUNCTION; OVARY INSUFFICIENCY; PRIORITY JOURNAL; RHABDOMYOSARCOMA;

EID: 0030934434     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.771575.x     Document Type: Article

References (7)

1. Chatterjee, R., Mills, W., Katz, M., McGarrigle, H.H. & Goldstone, A.H. (1993) Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy. Leukaemia and Lymphoma, 10, 383-386.
2. Kumar, R., Biggart, J.D. & McEvoy, J. (1972) Cyclophosphamide and reproductive function. Lancet, i, 1212-1214.
3. Ratcliffe, J.M., McElhatton, P.R. & Sullivan, F.M. (1995) Reproductive Toxicity. In General and Applied Toxicology (eds B. Ballantyne, T. Marrs & P. Turner), pp. 925-956. Macmillan Press, UK.
4. Sobrinho, L.G., Levine, R.A. & DeConti, R.C. (1971) Amenorrhoea in patients with Hodgkin's disease treated with anti-neoplastic agents. American Journal of Obstetrics and Gynaecology, 109, 135-139.
5. Triantafilo, Y., Arteaga, E., Duque, G., Fernandez, C. & Grebe, G. (1991) [Pregnancy in a patient with premature ovarian failure secondary to chemotherapy]. Revista Medica de Chile, 119, 60-63.
6. Uldhall, P.R., Kerr, D.N.S. & Tacchi, D. (1972) Sterility and cyclophosphamide. Lancet, i, 693-694.
7. Wallace, W.H.B., Shalet, S.M., Crowne, E.C., Morris-Jones, P.M., Gattamaneni, H.R. & Price, D.A. (1989) Gonadal dysfunction due to cis-platinum. Medical and Paediatric Oncology, 17, 409-413.